1. Home
  2. CCEL vs RGS Comparison

CCEL vs RGS Comparison

Compare CCEL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • RGS
  • Stock Information
  • Founded
  • CCEL 1989
  • RGS 1922
  • Country
  • CCEL United States
  • RGS United States
  • Employees
  • CCEL N/A
  • RGS N/A
  • Industry
  • CCEL Managed Health Care
  • RGS Other Consumer Services
  • Sector
  • CCEL Health Care
  • RGS Consumer Discretionary
  • Exchange
  • CCEL Nasdaq
  • RGS Nasdaq
  • Market Cap
  • CCEL 34.8M
  • RGS 70.8M
  • IPO Year
  • CCEL 1997
  • RGS 1991
  • Fundamental
  • Price
  • CCEL $4.55
  • RGS $30.30
  • Analyst Decision
  • CCEL Strong Buy
  • RGS
  • Analyst Count
  • CCEL 1
  • RGS 0
  • Target Price
  • CCEL $8.50
  • RGS N/A
  • AVG Volume (30 Days)
  • CCEL 10.6K
  • RGS 13.0K
  • Earning Date
  • CCEL 10-15-2025
  • RGS 11-05-2025
  • Dividend Yield
  • CCEL 13.19%
  • RGS N/A
  • EPS Growth
  • CCEL N/A
  • RGS 20.23
  • EPS
  • CCEL N/A
  • RGS 46.10
  • Revenue
  • CCEL $31,747,500.00
  • RGS $210,134,000.00
  • Revenue This Year
  • CCEL $1.75
  • RGS N/A
  • Revenue Next Year
  • CCEL N/A
  • RGS N/A
  • P/E Ratio
  • CCEL N/A
  • RGS $0.69
  • Revenue Growth
  • CCEL N/A
  • RGS 3.52
  • 52 Week Low
  • CCEL $4.09
  • RGS $15.00
  • 52 Week High
  • CCEL $9.43
  • RGS $31.50
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 47.89
  • RGS 63.56
  • Support Level
  • CCEL $4.35
  • RGS $28.74
  • Resistance Level
  • CCEL $4.60
  • RGS $31.50
  • Average True Range (ATR)
  • CCEL 0.13
  • RGS 1.00
  • MACD
  • CCEL -0.00
  • RGS -0.17
  • Stochastic Oscillator
  • CCEL 54.26
  • RGS 63.92

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: